20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7208 | AMD 3465 hexahydrobromide | GENZ-644494 (hexahydrobromide) | HIV Protease , CXCR |
AMD 3465 hexahydrobromide (GENZ-644494 (hexahydrobromide)) is a CXCR4 receptor antagonist with potential anticancer and anti-HIV activity. | |||
T22565 | AMD-070 hydrochloride | CXCR | |
AMD-070 hydrochloride is a CXCR4 antagonist, is useful for Anti HIV. | |||
TQ0174 | Mavorixafor | AMD-070 | CXCR |
Mavorixafor (AMD-070) is an effective and selective antagonist of CXCR4, with an IC50 value of 13 nM against CXCR4 125I-SDF binding. Mavorixafor inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells (IC... | |||
T29957 | AMD-7049 | AMD 7049 | |
AMD-7049 is a biochemical. | |||
T1776 | Plerixafor | JM3100,AMD 3100,AMD-3329 | Virus Protease , HIV Protease , CXCR |
Plerixafor (AMD-3329), a chemokine receptor antagonist, blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4. | |||
T29958 | AMD-9370 | ||
AMD-9370 is a biochemical. | |||
T14208 | AMD 3465 | GENZ-644494 | HIV Protease |
AMD 3465 also potently inhibits the replication of X4 HIV strains (IC50: 1-10 nM). However, it has no effect on CCR5-using (R5) viruses. AMD 3465 (GENZ-644494) is a potent antagonist of CXCR4, inhibits binding of 12G5 mA... | |||
T1776L | Plerixafor octahydrochloride | JM3100 octahydrochloride,Plerixafor 8HCl (AMD3100 8HCl),Plerixafor 8HCl,SID791 octahydrochloride,AMD 3100 octahydrochloride,JM 3100 8HCl | Virus Protease , HIV Protease , CXCR |
Plerixafor octahydrochloride (JM3100 octahydrochloride) blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow a... | |||
T70260 | AMD-3329 hydrobromide | ||
AMD-3329 hydrobromide is a biochemical in the class of potent and selective anti-HIV-1 and HIV-2 agents that inhibit virus replication by binding to the chemokine receptor CXCR4, the co-receptor for entry of X4 viruses. | |||
T69583 | AMD-3451 trihydrochloride | ||
AMD-3451 trihydrochloride is a CCR5/CXCR4 dual antagonist that may be useful in the treatment of HIV. | |||
T69582 | AMD-3451 free base | ||
AMD-3451 free base is a dual CCR5/CXCR4 antagonist which may be useful in the treatment of a wide variety of R5, R5/X4, and X4 strains of human immunodeficiency virus type 1 (HIV-1) and HIV-2. AMD3451 is the first low-mo... | |||
T70259 | AMD-3329 free base | ||
AMD-3329 free base is a biochemical in the class of potent and selective anti-HIV-1 and HIV-2 agents that inhibit virus replication by binding to the chemokine receptor CXCR4, the co-receptor for entry of X4 viruses. | |||
T10296 | Mavorixafor trihydrochloride | AMD-070 trihydrochloride | HIV Protease |
Mavorixafor trihydrochloride is a selective and orally available CXCR4 antagonist (IC50: 13 nM against CXCR4 125I-SDF binding) and also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs (I... | |||
T21323 | Picoplatin | NX 473,AMD-473,AMD473,NX-473,NX473,AMD 473 | |
Picoplatin has a broad spectrum of antineoplastic activity and is designed to overcome platinum drug resistance. Picoplatin alkylates DNA, forming both intra- and inter-strand cross-linkages, resulting in the inhibition ... | |||
T8574 | SPHINX | Others | |
SPHINX is a new generation inhibitor of SPRK1 | |||
T9928 | Ranibizumab | VEGFR | |
Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth factor (VEGF), including VEGF110, VEGF121, and VEGF165. Ranibizumab's ability to selectively target and n... | |||
T23716 | AMDE-1 | AMDE 1 | Autophagy |
AMDE-1 is an autophagy modulator and triggers autophagy in an Atg5-dependent manner. AMDE-1 recruits Atg16 to the pre-autophagosomal site and causes LC3 lipidation. | |||
T29959 | Amdinocillin methylacetate | Mecillinam acetylmethyl ester | |
Amdinocillin methylacetate is a Synthetic penicillin. | |||
T26615 | Amdoxovir | AMDX,DAPD | |
Amdoxovir is a reverse transcriptase inhibitor. | |||
T39327 | Amdizalisib | Amdizalisib,HMPL-689 | |
Amdizalisib is a PI3K inhibitor and used for the research of inflammatory disease, autoimmune disease or cancer. |